Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Pharmaxis Ltd ( (AU:SNT) ).
Syntara Limited has updated its corporate governance framework to align with the ASX Governance Principles, ensuring robust management and oversight structures. The framework includes a board charter, director checks, written agreements with executives, and a direct accountability structure for the company secretary, enhancing transparency and governance integrity.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.06 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Syntara Limited is an Australian company listed on the Australian Securities Exchange (ASX). The company has developed a corporate governance framework consistent with the ASX Governance Principles, focusing on management oversight, board structure, ethical culture, corporate report integrity, timely disclosure, security holder rights, risk management, and fair remuneration.
Average Trading Volume: 7,328,631
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$42.32M
For a thorough assessment of SNT stock, go to TipRanks’ Stock Analysis page.